AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Tranexamic Acid BP
6 registrations across 4 African markets— 5 active
Markets with Tranexamic Acid BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SANOTRAN INJECTION (Each 5ml contains Tranexamic acid BP 500mg) | 🇬🇭Ghana | — | active | May 2031 |
| SANOTRAN INJECTION (Each 5ml contains Tranexamic acid BP 500mg) | 🇬🇭Ghana | — | active | May 2031 |
| XANTRA INJECTION 500mg/5ml Solution For Injection | 🇰🇪Kenya | AGIO PHARMACEUTICALS LTD | active | May 2030 |
| UNOTATION TABLET/1X10 | 🇳🇬Nigeria | UNOSOURCE PHARMA NIG. LTD. 47 | expired | Jan 2022 |
| TRANLOK 500 IV Injection | 🇹🇿Tanzania | Aristo Pharmaceuticals Private Limited | active | — |
| INDTREX-500 liquid injection | 🇹🇿Tanzania | Indasi Lifescience Pvt. Ltd. | active | — |
Tranexamic Acid BP in Africa — Regulatory Overview
Tranexamic Acid BP is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Tanzania, Kenya, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.